Inert crystal delivery medium for serial femtosecond crystallography

US10775322B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10775322-B2
Application numberUS-201615183149-A
CountryUS
Kind codeB2
Filing dateJun 15, 2016
Priority dateJun 16, 2015
Publication dateSep 15, 2020
Grant dateSep 15, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A system and method for preparing a crystal delivery medium comprising agarose for serial femtosecond crystallography and uses thereof.

First claim

Opening claim text (preview).

We claim: 1. A method for preparation of an inert crystal delivery medium, the method comprising the steps of: preparing an agarose solution comprising agarose, a cryoprotectant, and a first crystallization buffer; preparing a crystal solution comprising a plurality of ordered and symmetrically packed membrane-bound protein crystals and a second crystallization buffer, wherein membrane-bound protein of the membrane-bound protein crystals is insoluble in water; and mixing the crystal solution and the agarose solution such that the plurality of membrane-bound protein crystals are suspended within the agarose solution to form an inert crystal delivery medium comprising the plurality of membrane-bound protein crystals, 5.5%-10% (w/v) agarose, the cryoprotectant, the first crystallization buffer, and the second crystallization buffer. 2. The method of claim 1 , wherein the crystal solution is contained within a first syringe, the agarose solution is contained within a second syringe, and the first and second syringes are coupled to mix the crystal solution and agarose solution and, thereby, form the inert crystal delivery medium. 3. The method of claim 1 , wherein the cryoprotectant is provided at a concentration sufficient to prevent formation of ice. 4. The method of claim 1 wherein the first crystallization buffer of the agarose solution and the second crystallization buffer of the crystal solution are the same crystallization buffer. 5. The method of claim 1 , wherein the plurality of the membrane-bound protein crystals comprises crystals of between 100 nm to 40 μm in size. 6. The method of claim 5 , wherein the crystals are between 1 to 10 μm in size. 7. A crystal delivery medium, the medium comprising: ordered and symmetrically packed membrane-bound protein crystals, wherein membrane-bound protein of the membrane-bound protein crystals is insoluble in water; 5.5%-10% (w/v) agarose; a cryoprotectant; and a crystallization buffer. 8. The medium of claim 7 , wherein the cryoprotectant is a polyethylene glycol. 9. The medium of claim 7 , wherein the cryoprotectant is a sugar. 10. The medium of claim 7 , wherein the cryoprotectant is provided at a concentration sufficient to prevent formation of ice. 11. The medium of claim 7 , wherein the cryoprotectant is selected from the group consisting of polyethylene glycols, glycerol, ethylene glycol, non-volatile organics, osmolytes, polyols, sugars, oils, and mixtures thereof. 12. The medium of claim 11 , wherein the cryoprotectant is selected from the group consisting of polyethylene glycols, glycerol, ethylene glycol, sugars, and mixtures thereof. 13. A system for preparation of a crystal delivery medium for serial femtosecond crystallography, the system comprising: ordered and symmetrically packed membrane-bound protein crystals, wherein the membrane-bound protein of the membrane-bound protein crystals is insoluble in water; an agarose solution comprising 5.5%-10% (w/v) agarose, a cryoprotectant, and a crystallization buffer; and a first syringe, a second syringe, and a syringe coupler for mixing the membrane protein crystals into the agarose solution. 14. The system of claim 13 , wherein the cryoprotectant is provided at a concentration sufficient to prevent formation of ice.

Assignees

Inventors

Classifications

  • Macromolecular compounds · CPC title

  • Preparation of powder samples therefor · CPC title

  • Physical analysis of biological material · CPC title

  • the crystallising materials being formed by chemical reactions in the solution · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10775322B2 cover?
A system and method for preparing a crystal delivery medium comprising agarose for serial femtosecond crystallography and uses thereof.
Who is the assignee on this patent?
Univ Arizona State
What technology area does this patent fall under?
Primary CPC classification G01N23/2005. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Sep 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).